Bioanalytical outsourcing soars as drugs grow more complex
Outsourcing of bioanalytical lab services is set for explosive growth as the increasingly complex nature of modern-day therapeutics makes partnerships with CROs indispensable.
Net-zero pledge: CDMOs go greener
A number of CDMOs are accelerating their environmental drive as sustainability goals become one of the most urgent business strategies facing pharma companies today.
Powering up antibody-drug conjugates with PROTACS
Read this White Paper on the ADC alternative that is capturing scientists’ imagination – antibody-linked PROTACs and the impact it could have in oncology, neurology, virology, and agriculture.
Integrated or Standalone: How the industry thinks about drug development outsourcing
Read this white paper to gain insights about perceptions around integrated and standalone outsourcing. The white paper is based on surveys conducted across emerging biopharma, mid-size and large pharma in North America, Europe and other regions.
Hyaluronic Acid – A wonder molecule for the cosmetic and pharma industries
Understanding the many application areas of Hyaluronic acid in the cosmetic and pharma space, including possibilities for the future.